Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cantor Fitzgerald
Farmers Insurance
US Army
Julphar
Colorcon
McKesson
Teva
Fuji

Generated: November 15, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Cipla

« Back to Dashboard

Cipla Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Cipla Limited lamivudine; zidovudine 202814 30MG; 60MG TABLET, FOR SUSPENSION; ORAL
Cipla Limited efavirenz; emtricitabine; tenofovir disoproxil fumarate 091593 300MG TABLET; ORAL
Cipla Limited lamivudine; zidovudine; nevirapine 021971 150MG; 300MG; 200MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
Harvard Business School
Cipla
McKesson
Chubb
Cerilliant
US Army
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.